Investments in and Advances to Unconsolidated Joint Ventures

6 Months Ended

Jun. 30, 2017

The Company owns interests in the following entities that are accounted for under the equity method at June 30, 2017 (dollars in thousands):



				Carrying Amount
				June 30,		December 31,
Entity ⁽¹⁾	Segment	Ownership%		2017		2016
CCRC JV ⁽²⁾	SHOP		49	$	433,507	$	439,449
RIDEA II	SHOP		40	258,505		—
HCP Life Science ⁽³⁾	Life science		50 - 63	64,795		67,879
MBK JV	SHOP		50	38,806		38,909
Medical Office JVs ⁽⁴⁾	Medical office		20 - 67	13,569		13,438
Development JVs ⁽⁵⁾	SHOP		50 - 90	18,616		10,459
K&Y JVs	Other non-reportable segments		80	1,420		1,342
Advances to unconsolidated joint ventures, net				13		15
				$	829,231	$	571,491

_______________________________________


(1)	These entities are not consolidated because the Company does not control, through voting rights or other means, the JV.


(2)	Includes two unconsolidated JVs in a RIDEA structure (CCRC PropCo and CCRC OpCo).


(3)	Includes the following unconsolidated partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).


(4)	Includes three unconsolidated medical office partnerships (and the Company’s ownership percentage): HCP Ventures VI, LLC (20%); HCP Ventures III, LLC (30%); and Suburban Properties, LLC (67%).


(5)	Includes four unconsolidated SHOP development partnerships (and the Company’s ownership percentage): (i) Vintage Park Development JV (85%); (ii) Waldwick JV (85%); (iii) Otay Ranch JV (90%); and (iv) MBK Development JV (50%).

See Note 4 for further information on the deconsolidation of RIDEA II.